FDA Challenges Execution Drug Ban In DC Circ.

Law360, Washington (March 25, 2013, 5:04 PM EDT) -- The U.S. Food and Drug Administration urged the D.C. Circuit on Monday to toss an order that blocks states and others from importing an unapproved anesthetic to use in lethal injection executions, saying the lower court ruling could limit the agency's ability to enforce import standards as it sees fit.

A group of death row prisoners claimed the agency's decision to allow unapproved, foreign sodium thiopental imports could subject them to subpar anesthesia prior to their executions and violates the Food, Drug and Cosmetic Act. But...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.